Select Site 
Eric Dube

Eric Dube

President and CEO | Retrophin

Dr. Dube is the President and Chief Executive Officer of Retrophin, Inc., and serves as a member of the company's Board of Directors. He is a results-driven leader with a record of delivering innovative therapies to address significant unmet patient needs. With leadership experience across the United States, Europe and Japan, Dr. Dube draws upon significant expertise in managing commercial, operations, market access, medical, and business development functions. He leads with a commitment to patients, integrating their perspective into all aspects of the company's operations.

Prior to joining Retrophin, Dr. Dube was President and Head of North America at ViiV Healthcare, where he led the commercialization of pipeline assets and oversaw the governance of all pricing, strategy, policy, and investment decisions for the company's North America business. Before joining ViiV, for more than 18 years he worked in roles of increasing leadership at GlaxoSmithKline plc, spanning critical areas, including sales, marketing, market access, medical affairs, compliance, supply chain, and alliance management. During Dr. Dube's tenure at GSK, he also led the U.S. Oncology and Global Respiratory businesses.

Dr. Dube has previously been named a Fortune magazine "40 Under 40: Ones to Watch" and one of the "Emerging Pharma Leaders" by Pharmaceutical Executive. He has also been named by the Financial Times as one of the "OUTstanding 100 LGBT+ Executives."




An AIDS-Free Generation
is possible.

We can't get there without you.

Click here to make a tax-deductible donation today.


Thank you for contacting DC Web Designers. We will be in touch shortly.

ERROR: Message Not Sent!